Rush Immunotherapy is quickly becoming the preferred method for providing rapid relief from allergies. Seasonal or persistent nasal itching, sneezing, runny nose, nasal congestion, sinus headaches, postnasal drainage and sleep disturbance because of nasal obstruction, as well as itching and burning of the eyes, affects 10 to 25 percent of people in western countries. Pollen and airborne substances from molds, animals, mites and other insects are common causes.
Allergic reactions in lungs result in asthma in approximately five percent of the world's population. Tightness in the chest, shortness of breath, wheezing and coughing are common asthma symptoms. Asthma can limit activities, disrupt sleep and affect quality of life. Acute respiratory tract infections or exposure to allergic triggers can cause severe or even fatal asthma.
The goals of therapy for upper airway allergic reactions include relief from annoying symptoms, relief from disturbed sleep and middle ear or sinus infections.
Antihistamines, decongestants, nasal steroid sprays and other nasal allergy sprays often provide relief. The goals for asthma are control of the symptoms, prevention of limitations on activities and protection from worsening during infections or exposures to allergic triggers.
Allergic rhinitis, allergic conjunctivitis and allergic asthma, often need immunotherapy, such as allergy shots -- currently the only therapy able to reduce or eliminate the body's unwanted allergic reactions.
Rush Immunotherapy is a new injection procedure revolutionizing how we treat allergies. Traditional immunotherapy typically involves injections twice a week with increasing amounts of antigens (the substances that cause the allergies). This process usually takes 16 weeks to reach full treatment doses (maintenance doses).
The Rush Immunotherapy revolution centers on the belief that relief from allergy symptoms requires lower doses of antigens than required to make eliminate allergies entirely. Research in United States and Europe has led to Rush Immunotherapy procedures allowing us to reach levels of antigens that begin to relieve symptoms in one day rather than two to three months.
Patients are given high doses of allergy suppressing medication to minimize reactions at the sites of injections or in the rest of the body. Typically eight injections are given over a period of five hours and the patients are then observed for two more hours as the materials are absorbed into the body.
The initial treatment requires a full day in the office. In doing so, we avoid nearly three-quarters of the visits needed to build up to maintenance doses. A day in the office also affords time for the patient to ask questions about allergic disease and treatment.
Not everyone is a good candidate for Rush Immunotherapy. If asthma control is not stable or if lung functions are not near normal, Rush Immunotherapy may not be safe.
For many patients, Rush ImmunotheWrapy is an alternative with several advantages over medications alone or traditional immunotherapy.
Rush Immunotherapy provides a method for achieving clinical improvement very rapidly and greatly reduces the number of visits required to achieve long lasting freedom from allergy.